Authors: Firon, M Shaharabany, M Altstock, RT Horev, J Abramovici, A Resau, JH Vande Woude, GF Tsarfaty, I

Citation: M. Firon et al., Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells, ONCOGENE, 19(20), 2000, pp. 2386-2397

Authors: Altstock, RT Stein, GY Resau, JH Tsarfaty, I

Citation: Rt. Altstock et al., Algorithms for quantitation of protein expression variation in normal versus tumor tissue as a prognostic factor in cancer: Met oncogene expression, and breast cancer as a model, CYTOMETRY, 41(3), 2000, pp. 155-165

Authors: Ronen, D Altstock, RT Firon, M Mittelman, L Sobe, T Resau, JH Woude, GFV Tsarfaty, I

Citation: D. Ronen et al., Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells, CELL GROWTH, 10(2), 1999, pp. 131-140

Authors: Tsarfaty, I Alvord, WG Resau, JH Altstock, RT Lidereau, R Bieche, I Bertrand, F Horev, J Klabansky, RL Keydar, I Vande Woude, GF

Citation: I. Tsarfaty et al., Alteration of Met protooncogene product expression and prognosis in breastcarcinomas, ANAL QUAN C, 21(5), 1999, pp. 397-408

Authors: Fabian, I Halperin, D Lefter, S Mittelman, L Altstock, RT Seaon, O Tsarfaty, I

Citation: I. Fabian et al., Alteration of actin organization by jaspamide inhibits ruffling, but not phagocytosis or oxidative burst, in HL-60 cells and human monocytes, BLOOD, 93(11), 1999, pp. 3994-4005